The Zhitong Finance App learned that Windward Bio Group, a clinical-stage biotech company headquartered in Switzerland, submitted an initial public offering (IPO) application to the US Securities and Exchange Commission (SEC) last Friday to raise up to 100 million US dollars.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.